Matching Drugs to Genetic Abnormalities to Precisely Treat Cystic Fibrosis

episode

JAMA Clinical Reviews not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Buds hit the desert | OverDrive: Sept. 24, 2026 - Hour 1 46 min · 24 Sep 2026 · OverDrive

NPR News: 09-24-2026 5PM EDT 5 min · 24 Sep 2026 · NPR News Now

David Faulkner: Property Brokers General Manager of Property Management on improving rental affordability 3 min · 24 Sep 2026 · The Mike Hosking Breakfast

What’s Behind Zuckerberg’s AI Optimism?; Is the Battle for White House Press Access Over? 28 min · 24 Sep 2026 · Here's the Scoop

H2 Program Picks w/ Fat Jack, Stump the Chumps 42 min · 24 Sep 2026 · The Program

McCabe on joining the Devils, his managerial view and New Jersey's style of play 13 min · 24 Sep 2026 · OverDrive

Report any issue

Source

Recorded05 Dec 2017

Publisherjamaclinicalreviews.libsyn.com ↗

Handlerec:7722879

Show notes

Cystic fibrosis is a common autosomal recessive disease. It is caused by any one of many discrete genetic abnormalities that affect chloride transport. Identification of specific genetic abnormalities enables clinicians to identify drugs that counteract the effects of the abnormal genes. In this podcast we review how genetic defects that cause cystic fibrosis are identified and how drugs that are likely to successfully treat the disease are matched to those genetic abnormalities. Related article

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in